Related references
Note: Only part of the references are listed.Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner
Nina Wiedmaier et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin α2β1
Ming-Tsan Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cysteine-rich 61 (CCN1) enhances chemotactic migration, tran send othelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2
Been-Ren Lin et al.
MOLECULAR CANCER RESEARCH (2007)
Phospholipase Cε is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation
Simona Citro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness
Nicholas Young et al.
EXPERIMENTAL CELL RESEARCH (2007)
Cytotoxicity of TNFα is regulated by integrin-mediated matrix signaling
Chih-Chiun Chen et al.
EMBO JOURNAL (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
Tumor necrosis factor-α-stimulated cell proliferation is mediated through sphingosine kinase-dependent akt activation and cyclin D expression
Julie Radeff-Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
Andrew Leask et al.
JOURNAL OF CELL SCIENCE (2006)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
B Visentin et al.
CANCER CELL (2006)
Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells
N Nguyen et al.
CANCER RESEARCH (2006)
Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-κB/cyclooxygenase-2 signaling pathway
MT Lin et al.
CLINICAL CANCER RESEARCH (2005)
Protease-activated receptors in hemostasis, thrombosis and vascular biology
SR Coughlin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1
JN McLaughlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data
A Hsiao et al.
NUCLEIC ACIDS RESEARCH (2005)
Cyr61 mediates the expression of VEGF, αv-integrin, and α-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells
DM Zhou et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
CCN proteins and cancer: Two to tango
AM Bleau et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway
M Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
A novel CYR61-triggered 'CYR61-αvβ3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway
JA Menendez et al.
ONCOGENE (2005)
The small GTP-binding protein RhoA regulates c-Jun by a ROCK-JNK signaling axis
MJ Marinissen et al.
MOLECULAR CELL (2004)
Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways
D Xie et al.
CANCER RESEARCH (2004)
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas
D Xie et al.
CLINICAL CANCER RESEARCH (2004)
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
MA Booden et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1
T Yamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rho signaling in vascular diseases
TM Seasholtz et al.
MOLECULAR INTERVENTIONS (2004)
Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes
A Hsiao et al.
BIOINFORMATICS (2004)
Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid
S Sakamoto et al.
ENDOCRINOLOGY (2004)
Identification of a novel integrin αvβ3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells
NY Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a novel integrin α6β1 binding site in the angiogenic inducer CCN1 (CYR61)
SJ Leu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways -: Role of CREB and AP-1 transcription factors
JS Han et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Comparison of prostaglandin F2α, Bimatoprost (Prostamide), and Butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression
YB Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of a novel integrin αMβ2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions
JM Schober et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lentivirus-delivered stable gene silencing by RNAi in primary cells
SA Stewart et al.
RNA (2003)
Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells
SJ Leu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyr61 promotes breast tumorigenesis and cancer progression
MS Tsai et al.
ONCOGENE (2002)
Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway
UR Pendurthi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways
I Tamura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
CYR61 stimulates human skin fibroblast migration through integrin αvβ5 and enhances mitogenesis through integrin αvβ3, independent of its carboxyl-terminal domain
TM Grzeszkiewicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Breast cancer -: Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease
D Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways
CB Martin et al.
ONCOGENE (2001)
Rho GTPase-dependent transformation by G protein-coupled receptors
IP Whitehead et al.
ONCOGENE (2001)
Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans
NY Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa•tissue factor-induced signal transduction
UR Pendurthi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
